124 related articles for article (PubMed ID: 10823105)
1. Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment.
Patel A; Harrison E; Durward A; Murdoch IA
Br J Anaesth; 2000 Apr; 84(4):505-7. PubMed ID: 10823105
[TBL] [Abstract][Full Text] [Related]
2. The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: a pilot study.
Silverman RA; Foley F; Dalipi R; Kline M; Lesser M
Respir Med; 2012 Aug; 106(8):1096-102. PubMed ID: 22580235
[TBL] [Abstract][Full Text] [Related]
3. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
[TBL] [Abstract][Full Text] [Related]
4. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
[TBL] [Abstract][Full Text] [Related]
5. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
[TBL] [Abstract][Full Text] [Related]
6. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
Spencer DA
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
[No Abstract] [Full Text] [Related]
7. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).
Kamin W; Klär-Hlawatsch B; Truebel H
Klin Padiatr; 2006; 218(2):88-91. PubMed ID: 16506110
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
Minasian C; Wallis C; Metcalfe C; Bush A
Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
[TBL] [Abstract][Full Text] [Related]
9. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
Conway SP; Watson A
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
[No Abstract] [Full Text] [Related]
10. Where we are now with rhDNase.
Geddes DM; Shah PL
Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
[No Abstract] [Full Text] [Related]
11. [Clinical development of rhDNase in the United States].
Eisenberg J
Arch Pediatr; 1995 Jul; 2(7):674-8. PubMed ID: 7663659
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
Chen JJ; Hamilton SA
J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
[TBL] [Abstract][Full Text] [Related]
13. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
[TBL] [Abstract][Full Text] [Related]
15. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
von der Schulenburg JM; Greiner W; von der Hardt H
Med Klin (Munich); 1995 Apr; 90(4):220-4. PubMed ID: 7776934
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
Shak S
Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
[TBL] [Abstract][Full Text] [Related]
17. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
Slattery DM; Waltz DA; Denham B; O'Mahony M; Greally P
Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
[TBL] [Abstract][Full Text] [Related]
18. Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children.
Boeuf B; Prouix F; Morneau S; Marton D; Lacroix J
Pediatr Pulmonol; 1998 Aug; 26(2):147. PubMed ID: 9727769
[No Abstract] [Full Text] [Related]
19. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
[Next] [New Search]